About OmerosPipelineInvestorsNews

Investor Relations Home

Corporate Profile

Here you will find financial reports and shareholder information about Omeros Corporation, including recent news, current and historical share price, and electronic copies of our SEC filings.

Stock Quote
OMER (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) Stock is Up 0.39 (1.90%)
Data as of 08/17/18 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent Press ReleasesMore >>
08/10/18Omeros to Present at the 2018 Wedbush PacGrow Healthcare Conference
SEATTLE--(BUSINESS WIRE)--Aug. 10, 2018-- Omeros Corporation (NASDAQ: OMER), today announced that Gregory A. Demopulos, M.D., chairman and chief executive officer, will present at the 2018 Wedbush PacGrow Healthcare Conference in New York next week. The presentation is scheduled for Tuesday, August 14, 2018 at 2:30 p.m. EDT. The presentation will be webcast. The live and archived webcasts can be accessed on the “Events” page of the company... 
 Printer Friendly Version
08/09/18Omeros Corporation Reports Second Quarter 2018 Financial Results
– Conference Call Today at 4:30 p.m. ET – SEATTLE--(BUSINESS WIRE)--Aug. 9, 2018-- Omeros Corporation (NASDAQ: OMER) today announced recent highlights and developments as well as financial results for the second quarter ended June 30, 2018, which include: 2Q 2018 total and OMIDRIA® revenues were $1.7 million, compared to $17.2 million in 2Q 2017; the decrease was due to the significantly reduced usage of OMIDRIA by ambula... 
 Printer Friendly Version
08/03/18Omeros Corporation to Announce Second Quarter 2018 Financial Results on August 9, 2018
SEATTLE--(BUSINESS WIRE)--Aug. 3, 2018-- Omeros Corporation (NASDAQ: OMER) today announced that the company will issue its second quarter 2018 financial results for the period ended June 30, 2018, on Thursday, August 9, 2018, after the market closes. Omeros management will host a conference call and webcast that day at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss the financial results. Conference Call Details T... 
 Printer Friendly Version
08/02/18Omeros Hires Former Sanofi Global Development Head as Chief Medical Officer
– Company Expands Leadership to Keep Pace with Advancing Pivotal Clinical Programs – SEATTLE--(BUSINESS WIRE)--Aug. 2, 2018-- Omeros Corporation (Nasdaq: OMER) today announced that Eckhard Leifke, M.D. has been named Omeros’ Chief Medical Officer and Vice President of Clinical Development. In this role, Dr. Leifke will oversee clinical science & operations, medical affairs and pharmacovigilance. He assumes these corporate responsibilities ... 
 Printer Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
Featured Report
Download Documentation Corporate Presentation
Download Documentation 2017 Annual Report
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Omeros Corporation posts new information to the site. Just enter your e-mail address and click Submit.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.